SYSTEM OVERVIEW // Endometriosis

ENDOMETRIOSIS

Eight Years to Diagnosis. A Lifetime of Being Dismissed.

Endometriosis — the abnormal growth of endometrial-like tissue outside the uterus — affects 1.5 million UK women and takes an average 8 years to diagnose, during which women are routinely told their pain is normal. The biological drivers extend far beyond reproductive anatomy: immune dysregulation allowing ectopic tissue to survive, oestrogen dominance feeding lesion growth, dioxin and environmental toxin exposure, gut microbiome disruption creating the estrobolome imbalance that recycles oestrogen, and neuroinflammation explaining the chronic pain that persists even after surgical removal. This is a systemic immune-inflammatory condition that requires a systemic biological response.

1.5MUK Women Have Endometriosis

8yrsAverage Time to Diagnosis

£8.2BAnnual UK Economic Cost of Endometriosis

Keep this domain close

Follow Endometriosis to see new published articles in My INNERSTANDIN.

YOUR PROGRESS:

0 / 5 TRANSMISSIONS READ

LATEST RESEARCH

In-depth analysis of biological systems and environmental factors.

Progesterone Resistance: The Molecular Blockade to Hormonal Balance

This article dives into the molecular biology of progesterone resistance, explaining why many endometriosis patients do not respond to standard progestin treatments. We examine the downregulation of Progesterone Receptor-B (PR-B) and the epigenetic silencing of key genes. Understanding this resistance is crucial for moving beyond the 'more hormones' approach and toward restoring cellular sensitivity.

#Progesterone Resistance#Epigenetics

The Estrobolome Link: How Gut Dysbiosis Fuels Endometrial Lesions

Investigating the 'gut-pelvis axis,' this article explains how the estrobolome—a collection of gut bacteria responsible for estrogen metabolism—dictates the progression of endometriosis. We detail the mechanism of beta-glucuronidase activity and how Lipopolysaccharides (LPS) from the gut can trigger peritoneal inflammation. This systemic perspective reveals why gut health is not just a secondary symptom, but a primary driver of the disease's proliferation.

#Estrobolome#Microbiome

Beyond Retrograde Menstruation: The Coelomic Metaplasia Evidence

This investigative piece deconstructs the long-standing Sampson's theory of retrograde menstruation, arguing that it fails to account for the presence of endometriosis in pre-menarcheal girls and males. We explore the mechanism of coelomic metaplasia, where peritoneal cells transform into endometrial-like tissue under specific environmental stimuli. By understanding this cellular transformation, patients can move beyond 'damage control' and address the systemic triggers of tissue misidentification.

#Endometriosis#Coelomic Metaplasia

Dioxins and the Peritoneal Terrain: The Toxicological Drivers of Endometriosis

Exploring the intersection of toxicology and immunology, this piece examines the role of Dioxins and Polychlorinated Biphenyls (PCBs) in the development of endometriosis. We detail how these toxins activate the Aryl Hydrocarbon Receptor (AhR), leading to immune suppression and enhanced lesion survival. This article provides a critical look at how our modern environment compromises the body's ability to clear ectopic tissue.

The Mast Cell-Endometriosis Axis: The Neurological Basis of Pelvic Pain

This article explores the neuro-immunological cross-talk that drives chronic pelvic pain, specifically focusing on the infiltration of mast cells into endometriotic lesions. We examine how Nerve Growth Factor (NGF) and mast cell degranulation create a cycle of peripheral sensitization that persists even after surgical removal of lesions. By targeting the mast cell-nerve axis, we provide a biological framework for managing pain that standard analgesics often fail to reach.

#Mast Cells#Neuro-inflammation

Apr 2026